image
Consumer Defensive - Tobacco - NASDAQ - US
$ 6.5
-6.61 %
$ 3.25 M
Market Cap
0.01
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one XXII stock under the worst case scenario is HIDDEN Compared to the current market price of 6.5 USD, 22nd Century Group, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one XXII stock under the base case scenario is HIDDEN Compared to the current market price of 6.5 USD, 22nd Century Group, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one XXII stock under the best case scenario is HIDDEN Compared to the current market price of 6.5 USD, 22nd Century Group, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart XXII

image
$180.0$180.0$160.0$160.0$140.0$140.0$120.0$120.0$100.0$100.0$80.0$80.0$60.0$60.0$40.0$40.0$20.0$20.0$0.0$0.015 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '25
FINANCIALS
11.9 M REVENUE
-63.12%
-14 M OPERATING INCOME
68.95%
-15.2 M NET INCOME
89.23%
-14.3 M OPERATING CASH FLOW
73.91%
-139 K INVESTING CASH FLOW
-0.83%
16.8 M FINANCING CASH FLOW
-54.72%
5.96 M REVENUE
223.52%
-2.57 M OPERATING INCOME
37.19%
-4.33 M NET INCOME
5.00%
-2.98 M OPERATING CASH FLOW
32.33%
-59 K INVESTING CASH FLOW
-195.00%
-254 K FINANCING CASH FLOW
-7.26%
Balance Sheet 22nd Century Group, Inc.
image
Current Assets 11.5 M
Cash & Short-Term Investments 4.42 M
Receivables 2.2 M
Other Current Assets 4.9 M
Non-Current Assets 10.2 M
Long-Term Investments 0
PP&E 4.41 M
Other Non-Current Assets 5.74 M
20.40 %10.14 %22.62 %20.36 %26.48 %Total Assets$21.7m
Current Liabilities 9.96 M
Accounts Payable 2.4 M
Short-Term Debt 1.75 M
Other Current Liabilities 5.81 M
Non-Current Liabilities 7.7 M
Long-Term Debt 6.6 M
Other Non-Current Liabilities 1.1 M
13.59 %9.93 %32.88 %37.38 %6.21 %Total Liabilities$17.7m
EFFICIENCY
Earnings Waterfall 22nd Century Group, Inc.
image
Revenue 11.9 M
Cost Of Revenue 14.3 M
Gross Profit -2.4 M
Operating Expenses 11.6 M
Operating Income -14 M
Other Expenses 1.21 M
Net Income -15.2 M
15m15m10m10m5m5m00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)12m(14m)(2m)(12m)(14m)(1m)(15m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
-20.21% GROSS MARGIN
-20.21%
-117.44% OPERATING MARGIN
-117.44%
-127.66% NET MARGIN
-127.66%
-377.97% ROE
-377.97%
-69.97% ROA
-69.97%
-103.80% ROIC
-103.80%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis 22nd Century Group, Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -15.2 M
Depreciation & Amortization 1.26 M
Capital Expenditures -161 K
Stock-Based Compensation 380 K
Change in Working Capital 0
Others -4 M
Free Cash Flow -14.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets 22nd Century Group, Inc.
image
XXII has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership 22nd Century Group, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
10.5 K USD 1
9-12 MONTHS
7. News
22nd Century Announces Operation 100 – A 100mm VLN® Cigarette Designed to Reach Even More Adult Smokers Who Want to Reduce Their Nicotine Consumption 100mm Cigarettes Comprise Approximately Half the U.S. Market, Giving Even More Smokers a Familiar Choice as They Seek Ways to Change Their Smoking Behavior First FDA Submission Planned for Q4 2025 MOCKSVILLE, N.C.,, June 26, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced the advancement of a 100mm VLN® reduced nicotine content cigarette. globenewswire.com - 3 weeks ago
22nd Century Announces Second Partner VLN Product Deal as Part of Major Pinnacle Brand Expansion Agreement with Top-5 C-Store Chain Launching New Pinnacle VLN and Moist Snuff Products in More Than 1,700 Stores Across 27 States  MOCKSVILLE, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced major updates to its Pinnacle product manufacturing and marketing agreement with its top-5 c-store chain customer, including the launch of four new Pinnacle SKUs, including two in the low nicotine product category. globenewswire.com - 3 weeks ago
Emerging Growth Research Releases Q1 2025 Update Report on 22nd Century Group New York, New York--(Newsfile Corp. - May 21, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q1 2025 results. The report reflects the continued operational progress made under new management and the outlook for meaningful financial improvement in 2025. newsfilecorp.com - 1 month ago
22nd Century to Present at the Emerging Growth Conference on May 21, 2025 MOCKSVILLE, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) is pleased to announce that Larry Firestone, Chief Executive Officer, will present a brief corporate update at the Emerging Growth Conference on Wednesday, May 21, 2025, at 12:00 pm Eastern Time. globenewswire.com - 1 month ago
22nd Century Group, Inc. (XXII) Q1 2025 Earnings Call Transcript 22nd Century Group, Inc. (NASDAQ:XXII ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants Matt Kreps - IR Larry Firestone - CEO Dan Otto - CFO Conference Call Participants Andrew White - Emerging Growth Research Operator Welcome to 22nd Century Group's First Quarter 2025 Conference Call and Webcast. At this time, all participants have been placed in a listen-only mode. seekingalpha.com - 2 months ago
22nd Century Group Reports First Quarter 2025 Financial Results Sales Increase Approximately 50% Sequentially as 2025 Growth Strategy Drives New Sales Activity with Both Internal and External Brand Assets Across Multiple Categories globenewswire.com - 2 months ago
22nd Century Group Completes Sale of Needle Rock Farms Assets Further Strengthens Balance Sheet Cash Position MOCKSVILLE, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced closing of the sale of its Needle Rock Farms assets with net proceeds of approximately $770,000 after expenses. globenewswire.com - 2 months ago
22nd Century Group Further Reduces Debt by $1.0 Million Following Financing Transaction Year to Date Total Debt Reduction of approximately $3.8 Million MOCKSVILLE, N.C., May 07, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced that has repaid an additional $1 million in debt to its senior lender. globenewswire.com - 2 months ago
22nd Century Group to Announce First Quarter 2025 Results on May 13, 2025 MOCKSVILLE, N.C., May 05, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, will host a webcast on Tuesday, May 13, 2025, at 8:00 AM ET to discuss its 2025 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day. globenewswire.com - 2 months ago
22nd Century Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions MOCKSVILLE, N.C., April 17, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) has released the following notice according to THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF NEW YORK: globenewswire.com - 3 months ago
Emerging Growth Research Releases Quarterly Update Report on 22nd Century Group (XXII) Sheridan, Wyoming--(Newsfile Corp. - April 10, 2025) - Emerging Growth Research is pleased to release its latest quarterly update on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q4 2024 results. The report reflects the continued operational progress made under new management and the outlook for meaningful financial improvement in 2025. newsfilecorp.com - 3 months ago
22nd Century Revenue Growth from Continued Expansion of CMO Volume with New Filtered Cigar Agreements MOCKSVILLE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced execution of two new agreements from former customers to supply their filtered cigar products. globenewswire.com - 3 months ago
8. Profile Summary

22nd Century Group, Inc. XXII

image
COUNTRY US
INDUSTRY Tobacco
MARKET CAP $ 3.25 M
Dividend Yield 0.00%
Description 22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Contact 500 Seneca Street, Mocksville, NY, 14204 https://www.xxiicentury.com
IPO Date Jan. 26, 2011
Employees 56
Officers Mr. Robert P. Manfredonia Executive Vice President of Sales & Marketing Mr. James C. Morrison Technical Advisor & Regulatory Affairs Consultant Mr. Jonathan Staffeldt General Counsel & Secretary Mr. Daniel A. Otto Chief Financial Officer & Principal Accounting Officer Matthew Kreps Investor Relations Mr. Lawrence D. Firestone President, Chief Executive Officer & Chairman